The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term follow-up of pharmacokinetics (PK) and immunogenicity of the anti–PD-1 antibodies nivolumab (Nivo) and pembrolizumab (Pembro) in real-world practice.
 
Masahide Fukudo
No Relationships to Disclose
 
Kazuto Mishima
No Relationships to Disclose
 
Norihisa Kimura
No Relationships to Disclose
 
Yuichiro Shinden
No Relationships to Disclose
 
Takaaki Sasaki
Honoraria - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Pfizer
Consulting or Advisory Role - AstraZeneca; Lilly Japan; Novartis
 
Shunsuke Okumura
No Relationships to Disclose
 
Yoshinobu Ohsaki
No Relationships to Disclose
 
Jiro Uehara
No Relationships to Disclose
 
Akemi Yamamoto
No Relationships to Disclose
 
Gaku Tamaki
No Relationships to Disclose
 
Hidehiro Kakizaki
No Relationships to Disclose
 
Kan Kishibe
No Relationships to Disclose
 
Miki Takahara
No Relationships to Disclose
 
Tatsuya Hayashi
No Relationships to Disclose
 
Yasuaki Harabuchi
No Relationships to Disclose
 
Tatsuya Shonaka
No Relationships to Disclose
 
Kimiharu Hasegawa
No Relationships to Disclose
 
Takashi Ono
No Relationships to Disclose
 
Yoshikazu Tasaki
No Relationships to Disclose